HURA
Income statement / Annual
Last year (2024), TuHURA Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, TuHURA Biosciences Inc.'s net income was -$21.68 M.
See TuHURA Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$116.71 K
|
$0.00
|
$0.00
|
$0.00
|
$32.00 K
|
$10.00 K
|
$16.35 K
|
$24.53 K
|
$16.68 K
|
$10.29 K
|
| Gross Profit |
-$116.71 K
|
$0.00
|
$0.00
|
$0.00
|
-$32.00 K
|
-$10.00 K
|
-$16.35 K
|
-$24.53 K
|
-$16.68 K
|
-$10.29 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$13.34 M
|
$9.40 M
|
$7.93 M
|
$4.88 M
|
$11.82 M
|
$3.63 M
|
$3.66 M
|
$7.13 M
|
$5.00 M
|
$3.36 M
|
| General & Administrative Expenses |
$0.00
|
$4.14 M
|
$2.01 M
|
$2.38 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.20 M
|
$4.14 M
|
$2.01 M
|
$2.38 M
|
$9.73 M
|
$4.50 M
|
$4.72 M
|
$4.02 M
|
$3.30 M
|
$2.84 M
|
| Other Expenses |
$0.00
|
$16.22 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$17.53 M
|
$29.76 M
|
$9.93 M
|
$7.25 M
|
$21.54 M
|
$8.13 M
|
$8.38 M
|
$11.15 M
|
$8.30 M
|
$6.20 M
|
| Cost And Expenses |
-$17.65 M
|
$29.76 M
|
$9.93 M
|
$7.25 M
|
-$21.57 M
|
-$8.14 M
|
-$8.40 M
|
-$11.17 M
|
-$8.32 M
|
-$6.21 M
|
| Interest Income |
$361.63 K
|
$89.67 K
|
$57.35 K
|
$0.00
|
$0.00
|
$75.00 K
|
$60.70 K
|
$33.24 K
|
$457.00
|
$108.00
|
| Interest Expense |
$4.14 M
|
$18.69 K
|
$0.00
|
$629.29 K
|
$120.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$116.71 K
|
$177.38 K
|
$373.09 K
|
$380.69 K
|
$32.00 K
|
$10.00 K
|
$16.35 K
|
$24.53 K
|
$16.68 K
|
$10.29 K
|
| EBITDA |
-$17.43 M |
-$29.12 M |
-$9.56 M |
-$6.01 M |
-$38.15 M |
-$9.12 M |
-$8.03 M |
-$11.11 M |
-$8.07 M |
-$8.85 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$4.03 M
|
$447.89 K
|
$566.34 K
|
$238.47 K
|
-$16.73 M
|
-$982.00 K
|
$350.28 K
|
$36.35 K
|
$239.07 K
|
-$2.65 M
|
| Income Before Tax |
-$21.68 M
|
-$29.32 M
|
-$9.37 M
|
-$7.02 M
|
-$38.30 M
|
-$9.13 M
|
-$8.05 M
|
-$11.14 M
|
-$8.08 M
|
-$8.86 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$21.68 M
|
-$29.32 M
|
-$9.37 M
|
-$7.02 M
|
-$38.30 M
|
-$9.13 M
|
-$8.05 M
|
-$11.14 M
|
-$8.08 M
|
-$8.86 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.2136 |
-11.2906 |
-324.4846 |
-903.035 |
-2805.845 |
-1532.0025 |
-5524.995 |
-9491.475 |
-12950 |
-14525 |
| EPS Diluted |
-1.2136 |
-11.2906 |
-324.4846 |
-903.035 |
-2805.845 |
-1532.0025 |
-5524.995 |
-9491.475 |
-12950 |
-14525 |
| Weighted Average Shares Out |
$18.66 M
|
$752.91 K
|
$46.29 K
|
$27.83 K
|
$14.79 K
|
$5.97 K
|
$1.47 K
|
$1.19 K
|
$688.40
|
$625.63
|
| Weighted Average Shares Out Diluted |
$18.66 M
|
$752.91 K
|
$46.29 K
|
$27.83 K
|
$14.79 K
|
$5.97 K
|
$1.47 K
|
$1.19 K
|
$688.40
|
$625.63
|
| Link |
|
|
|
|
|
|
|
|
|
|
